Trumponomics is likely to boost the Indian IT and pharma sectors, particularly through opportunities created by tariffs on Chinese APIs and currency depreciation. Consumer spending, however, is expected to remain steady after initial volatility. The banking sector presents investment opportunities, with short-term gains in private banks and medium-term benefits in public sector banks.
